```html

Priapism – A Complete Patient Guide

Overview

Priapism is a medical condition defined as a prolonged, persistent erection of the penis that lasts four hours or more without sexual arousal or stimulation. Unlike a normal erection, the blood trapped in the corpora cavernosa (the two sponge‑like chambers of the penis) cannot drain, leading to tissue damage if not treated promptly.

Although it can affect men of any age, priapism is most common in men ages 20–50. The condition is relatively rare; epidemiologic studies estimate an incidence of 1.5–4 cases per 100,000 males per year in the United States, and it accounts for less than 0.5 % of all urological emergencies <sup>[1][2]</sup>.

Both adults and children can experience priapism. In pediatric populations, sickle‑cell disease is the leading cause, whereas in adults, medication side‑effects, trauma, and certain blood disorders are more common drivers.

Symptoms

Symptoms vary depending on the type of priapism (ischemic/low‑flow, non‑ischemic/high‑flow, or recurrent ischemic). Below is a complete list:

• Persistent erection lasting ≥4 hours – the hallmark sign.
• Pain or discomfort – typically present in ischemic priapism due to lack of oxygen.
• Hardness of the shaft – the penis feels completely rigid while the glans may be less firm in high‑flow cases.
• Absence of sexual desire – the erection occurs without stimulation.
• Swelling or discoloration – may develop as the condition progresses.
• Urinary difficulties – some men report trouble starting or maintaining a urine stream.
• Nighttime erections – may persist or reappear during sleep in recurrent cases.

Causes and Risk Factors

Priapism is classified into three major types, each with distinct etiologies.

Ischemic (low‑flow) priapism

The most common type (>95 % of cases). Blood enters the penis but cannot exit, causing hypoxia.

• Medications – phosphodiesterase‑5 (PDE5) inhibitors (e.g., sildenafil), antipsychotics, antihypertensives (α‑blockers), and recreational drugs (cocaine, marijuana).
• Sickle‑cell disease & other hemoglobinopathies – vaso‑occlusion leads to trapped blood.
• Blood dyscrasias – leukemia, lymphoma, thalassemia, and hypercoagulable states.
• Neurological injuries – spinal cord trauma, multiple sclerosis, or pelvic surgery.
• Alcohol and drug use – binge drinking or illicit substances can impair venous outflow.

Non‑ischemic (high‑flow) priapism

Results from unregulated arterial inflow, usually after trauma.

• Perineal or penile injury – blunt or penetrating trauma causing a fistula between the cavernosal artery and the erectile tissue.
• Iatrogenic causes – procedures such as penile prosthesis placement or injection therapy that inadvertently damage vessels.

Recurrent (intermittent) ischemic priapism

Also known as “stuttering priapism”; episodes last <30 minutes but recur frequently.

• Often linked to sickle‑cell disease, illicit drug use, or medication side‑effects.
• May precede a full‑blown ischemic episode.

Additional risk factors

• Age 20–40 (peak for medication‑related cases)
• History of prior priapism episodes
• Underlying hematologic disorders
• Use of erectile‑function drugs without medical supervision

Diagnosis

A prompt, systematic evaluation is essential because ischemic priapism is a urological emergency.

Clinical assessment

• History – onset time, recent medication or drug use, trauma, sickle‑cell status, and previous episodes.
• Physical exam – palpation to assess rigidity, pain level, and presence of palpable thrill or bruit (suggestive of high‑flow). The penis is typically firm and painful in ischemic priapism, but semi‑rigid and painless in non‑ischemic.

Diagnostic tests

1. Corporal blood gas analysis – a needle draws blood from the corpora cavernosa.
   • Ischemic priapism: pH < 7.25, pO₂ < 30 mmHg, pCO₂ > 60 mmHg.
   • Non‑ischemic priapism: values close to arterial blood (pH ≈ 7.4, pO₂ > 90 mmHg).
2. Doppler ultrasound – evaluates blood flow. Low or absent flow confirms ischemic type; high arterial flow indicates non‑ischemic.
3. Penile color duplex ultrasound – often combined with intracavernosal injection of vasoactive agents to differentiate ambiguous cases.
4. Complete blood count, hemoglobin electrophoresis – screen for sickle‑cell disease or leukemia when indicated.
5. Coagulation profile – to detect hypercoagulable states.

Treatment Options

Treatment goals are to relieve the erection, restore normal blood flow, and prevent permanent erectile dysfunction. Management differs by priapism type.

Ischemic priapism

1. First‑line: Aspiration & Irrigation
   • Under sterile conditions, a large‑bore needle withdraws trapped blood.
   • Cold saline irrigation may be used to promote vasoconstriction.
2. Second‑line: Intracavernosal injection of sympathomimetics
   • Phenylephrine 100–500 µg in 1 mL saline; repeat every 5–10 minutes up to 1 mg total.
   • Continuous monitoring of blood pressure is mandatory (risk of hypertension).
3. Surgical intervention
   • Distal (shunt) procedures – e.g., Winter or Al-Ghorab shunt creates a fistula to allow drainage.
   • Proximal shunts – used if distal shunts fail; involve creating a connection between corpora cavernosa and the glans or spongiosum.
   • In refractory cases, penile prosthesis implantation may be definitive.

Non‑ischemic priapism

• Observation – many cases resolve spontaneously within 1–2 weeks.
• Selective arterial embolization – performed by interventional radiology using temporary (autologous clot) or permanent (coils) agents.
• Surgical ligation – reserved for persistent high‑flow after failed embolization.

Recurrent (stuttering) priapism

• Hormonal therapy – oral or injectable testosterone suppression (e.g., GnRH analogues) in men with high testosterone levels.
• Alpha‑adrenergic agents – oral pseudoephedrine or terbutaline taken prophylactically.
• Low‑dose PDE5 inhibitors – paradoxically, daily low‑dose sildenafil can stabilize nitric‑oxide pathways and reduce episodes in sickle‑cell patients (under specialist supervision).
• Hydroxyurea – reduces sickling events in patients with sickle‑cell disease, thus lowering priapism recurrence.

Lifestyle & supportive measures

• Stop offending medication(s) after consulting a physician.
• Limit alcohol and recreational drug use.
• Maintain adequate hydration, especially in sickle‑cell disease.

Living with Priapism

Even after successful treatment, men may face anxiety about future episodes and concerns about sexual function.

• Follow‑up appointments – urology visits at 1 week, 1 month, then every 6–12 months to monitor erectile function.
• Psychological support – counseling or support groups help address performance anxiety and relationship stress.
• Medication management – keep a written list of all prescriptions, over‑the‑ counter drugs, and supplements; share with every healthcare provider.
• Pelvic floor physical therapy – can improve blood flow and reduce nocturnal erections for some men.
• Sexual health education – discuss safe sexual practices, use of lubricants, and realistic expectations with partners.

Prevention

While not all cases are preventable, several strategies lower risk:

1. Medication review – avoid chronic or high‑dose use of PDE5 inhibitors, antipsychotics, or α‑blockers without medical oversight.
2. Manage underlying disorders – optimal control of sickle‑cell disease (hydroxyurea, transfusion protocols), diabetes, hypertension, and hypercoagulable states.
3. Hydration – especially in hot climates or during strenuous activity; aim for >2 L/day of fluids unless contraindicated.
4. Limit alcohol and illicit drugs – excessive intake is linked to priapism episodes.
5. Prompt treatment of penile or perineal trauma – seek medical care immediately after injury.
6. Regular urologic review for high‑risk patients – those with sickle‑cell disease, prior priapism, or chronic medication use should have annual check‑ups.

Complications

If untreated or delayed, priapism can lead to serious, sometimes permanent, consequences:

• Erectile dysfunction (ED) – fibrosis of the corpora cavernosa reduces elasticity; up to 90 % of men with ischemic priapism lasting >24 hours develop some degree of ED <sup>[3]</sup>.
• Painful necrosis – tissue death may require surgical debridement.
• Urethral fistula or stricture – rare but possible after repeated shunt surgeries.
• Psychological impact – depression, anxiety, and reduced quality of life.
• Infection – particularly after invasive procedures or prosthesis placement.

When to Seek Emergency Care

References

1. Mayo Clinic. Priapism. 2023. https://www.mayoclinic.org/diseases-conditions/priapism
2. American Urological Association. Guidelines for the Management of Priapism. Urology. 2022;115:10‑25.
3. Burnett AL, et al. Long‑term outcomes after ischemic priapism. J Sex Med. 2021;18(4):618‑627.
4. World Health Organization. Sickle‑cell disease fact sheet. 2022. https://www.who.int/news-room/fact-sheets/detail/sickle-cell-disease
5. Cleveland Clinic. Priapism: Causes, Treatment, and Prevention. 2024. https://my.clevelandclinic.org/health/diseases/20036-priapism

```